| Literature DB >> 31676561 |
Abstract
GRM4, a GWAS-suspected tumor suppressor, is tested in a mouse model of osteosarcomagenesis as well as the putative oncogene it suppresses, IL23. Both are expressed in and exert the bulk of their influence among tumor-infiltrating myeloid-derived antigen-presenting cells, rather than osteosarcoma cells.See related article by Kansara et al., p. 1511. ©2019 American Association for Cancer Research.Entities:
Mesh:
Year: 2019 PMID: 31676561 DOI: 10.1158/2159-8290.CD-19-0994
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397